Molecular Cytogenetics Market Size, Share, and Trends 2025 to 2034

Molecular Cytogenetics Market (By Technique: Fluorescence In Situ Hybridization, Comparative Genomic Hybridization, Karyotyping, Array CGH, PCR-Based Cytogenetics; By Product: Instruments, Reagents & Kits, Software & Services; By Application: Oncology, Prenatal Diagnostics, Postnatal Diagnostics, Genetic Disorder Screening, Research Applications; By End-User: Hospitals & Diagnostic Laboratories, Academic & Research Institutes, Biotechnology & Pharmaceutical Companies, Contract Research Organizations; By Technology: Automated Systems, Manual Systems) - Global Industry Analysis, Size, Trends, Leading Companies, Regional Outlook, and Forecast 2025 to 2034

Last Updated : 04 Nov 2025  |  Report Code : 7058  |  Category : Healthcare   |  Format : PDF / PPT / Excel

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology  

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Molecular Cytogenetics Market 

5.1. COVID-19 Landscape: Molecular Cytogenetics Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Molecular Cytogenetics Market, By Technique

8.1. Molecular Cytogenetics Market Revenue and Volume, by Technique

8.1.1. Fluorescence In Situ Hybridization (FISH)

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Comparative Genomic Hybridization (CGH)

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Karyotyping

8.1.3.1. Market Revenue and Volume Forecast

8.1.4. Array CGH

8.1.4.1. Market Revenue and Volume Forecast

8.1.5. PCR-Based Cytogenetics

8.1.5.1. Market Revenue and Volume Forecast

Chapter 9. Global Molecular Cytogenetics Market, By Product

9.1. Molecular Cytogenetics Market Revenue and Volume, by Product

9.1.1. Instruments

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Reagents & Kits   

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Software & Services

9.1.3.1. Market Revenue and Volume Forecast

Chapter 10. Global Molecular Cytogenetics Market, By Application 

10.1. Molecular Cytogenetics Market Revenue and Volume, by Application

10.1.1. Oncology

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Prenatal Diagnostics

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Postnatal Diagnostics

10.1.3.1. Market Revenue and Volume Forecast

10.1.4. Genetic Disorder Screening

10.1.4.1. Market Revenue and Volume Forecast

10.1.5. Research Applications

10.1.5.1. Market Revenue and Volume Forecast

Chapter 11. Global Molecular Cytogenetics Market, By End-User

11.1. Molecular Cytogenetics Market Revenue and Volume, by End-User

11.1.1. Hospitals & Diagnostic Laboratories

11.1.1.1. Market Revenue and Volume Forecast

11.1.2. Academic & Research Institutes

11.1.2.1. Market Revenue and Volume Forecast

11.1.3. Biotechnology & Pharmaceutical Companies

11.1.3.1. Market Revenue and Volume Forecast

11.1.4. Contract Research Organizations

11.1.4.1. Market Revenue and Volume Forecast

11.1.5. Others

11.1.5.1. Market Revenue and Volume Forecast

Chapter 12. Global Molecular Cytogenetics Market, By Technology

12.1. Molecular Cytogenetics Market Revenue and Volume, by Technology

12.1.1. Automated Systems

12.1.1.1. Market Revenue and Volume Forecast

12.1.2. Manual Systems

12.1.2.1. Market Revenue and Volume Forecast

Chapter 13. Global Molecular Cytogenetics Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Volume Forecast, by Technique

13.1.2. Market Revenue and Volume Forecast, by Product

13.1.3. Market Revenue and Volume Forecast, by Application

13.1.4. Market Revenue and Volume Forecast, by End-User

13.1.5. Market Revenue and Volume Forecast, by Technology

13.1.6. U.S.

13.1.6.1. Market Revenue and Volume Forecast, by Technique

13.1.6.2. Market Revenue and Volume Forecast, by Product

13.1.6.3. Market Revenue and Volume Forecast, by Application

13.1.6.4. Market Revenue and Volume Forecast, by End-User

13.1.6.5. Market Revenue and Volume Forecast, by Technology  

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Volume Forecast, by Technique

13.1.7.2. Market Revenue and Volume Forecast, by Product

13.1.7.3. Market Revenue and Volume Forecast, by Application

13.1.7.4. Market Revenue and Volume Forecast, by End-User

13.1.7.5. Market Revenue and Volume Forecast, by Technology

13.2. Europe

13.2.1. Market Revenue and Volume Forecast, by Technique

13.2.2. Market Revenue and Volume Forecast, by Product

13.2.3. Market Revenue and Volume Forecast, by Application

13.2.4. Market Revenue and Volume Forecast, by End-User  

13.2.5. Market Revenue and Volume Forecast, by Technology  

13.2.6. UK

13.2.6.1. Market Revenue and Volume Forecast, by Technique

13.2.6.2. Market Revenue and Volume Forecast, by Product

13.2.6.3. Market Revenue and Volume Forecast, by Application

13.2.7. Market Revenue and Volume Forecast, by End-User  

13.2.8. Market Revenue and Volume Forecast, by Technology  

13.2.9. Germany

13.2.9.1. Market Revenue and Volume Forecast, by Technique

13.2.9.2. Market Revenue and Volume Forecast, by Product

13.2.9.3. Market Revenue and Volume Forecast, by Application

13.2.10. Market Revenue and Volume Forecast, by End-User

13.2.11. Market Revenue and Volume Forecast, by Technology

13.2.12. France

13.2.12.1. Market Revenue and Volume Forecast, by Technique

13.2.12.2. Market Revenue and Volume Forecast, by Product

13.2.12.3. Market Revenue and Volume Forecast, by Application

13.2.12.4. Market Revenue and Volume Forecast, by End-User

13.2.13. Market Revenue and Volume Forecast, by Technology

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Volume Forecast, by Technique

13.2.14.2. Market Revenue and Volume Forecast, by Product

13.2.14.3. Market Revenue and Volume Forecast, by Application

13.2.14.4. Market Revenue and Volume Forecast, by End-User

13.2.15. Market Revenue and Volume Forecast, by Technology

13.3. APAC

13.3.1. Market Revenue and Volume Forecast, by Technique

13.3.2. Market Revenue and Volume Forecast, by Product

13.3.3. Market Revenue and Volume Forecast, by Application

13.3.4. Market Revenue and Volume Forecast, by End-User

13.3.5. Market Revenue and Volume Forecast, by Technology

13.3.6. India

13.3.6.1. Market Revenue and Volume Forecast, by Technique

13.3.6.2. Market Revenue and Volume Forecast, by Product

13.3.6.3. Market Revenue and Volume Forecast, by Application

13.3.6.4. Market Revenue and Volume Forecast, by End-User

13.3.7. Market Revenue and Volume Forecast, by Technology

13.3.8. China

13.3.8.1. Market Revenue and Volume Forecast, by Technique

13.3.8.2. Market Revenue and Volume Forecast, by Product

13.3.8.3. Market Revenue and Volume Forecast, by Application

13.3.8.4. Market Revenue and Volume Forecast, by End-User

13.3.9. Market Revenue and Volume Forecast, by Technology

13.3.10. Japan

13.3.10.1. Market Revenue and Volume Forecast, by Technique

13.3.10.2. Market Revenue and Volume Forecast, by Product

13.3.10.3. Market Revenue and Volume Forecast, by Application

13.3.10.4. Market Revenue and Volume Forecast, by End-User

13.3.10.5. Market Revenue and Volume Forecast, by Technology

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Volume Forecast, by Technique

13.3.11.2. Market Revenue and Volume Forecast, by Product

13.3.11.3. Market Revenue and Volume Forecast, by Application

13.3.11.4. Market Revenue and Volume Forecast, by End-User

13.3.11.5. Market Revenue and Volume Forecast, by Technology

13.4. MEA

13.4.1. Market Revenue and Volume Forecast, by Technique

13.4.2. Market Revenue and Volume Forecast, by Product

13.4.3. Market Revenue and Volume Forecast, by Application

13.4.4. Market Revenue and Volume Forecast, by End-User

13.4.5. Market Revenue and Volume Forecast, by Technology

13.4.6. GCC

13.4.6.1. Market Revenue and Volume Forecast, by Technique

13.4.6.2. Market Revenue and Volume Forecast, by Product

13.4.6.3. Market Revenue and Volume Forecast, by Application

13.4.6.4. Market Revenue and Volume Forecast, by End-User

13.4.7. Market Revenue and Volume Forecast, by Technology

13.4.8. North Africa

13.4.8.1. Market Revenue and Volume Forecast, by Technique

13.4.8.2. Market Revenue and Volume Forecast, by Product

13.4.8.3. Market Revenue and Volume Forecast, by Application

13.4.8.4. Market Revenue and Volume Forecast, by End-User

13.4.9. Market Revenue and Volume Forecast, by Technology

13.4.10. South Africa

13.4.10.1. Market Revenue and Volume Forecast, by Technique

13.4.10.2. Market Revenue and Volume Forecast, by Product

13.4.10.3. Market Revenue and Volume Forecast, by Application

13.4.10.4. Market Revenue and Volume Forecast, by End-User

13.4.10.5. Market Revenue and Volume Forecast, by Technology

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Volume Forecast, by Technique

13.4.11.2. Market Revenue and Volume Forecast, by Product

13.4.11.3. Market Revenue and Volume Forecast, by Application

13.4.11.4. Market Revenue and Volume Forecast, by End-User

13.4.11.5. Market Revenue and Volume Forecast, by Technology

13.5. Latin America

13.5.1. Market Revenue and Volume Forecast, by Technique

13.5.2. Market Revenue and Volume Forecast, by Product

13.5.3. Market Revenue and Volume Forecast, by Application

13.5.4. Market Revenue and Volume Forecast, by End-User

13.5.5. Market Revenue and Volume Forecast, by Technology

13.5.6. Brazil

13.5.6.1. Market Revenue and Volume Forecast, by Technique

13.5.6.2. Market Revenue and Volume Forecast, by Product

13.5.6.3. Market Revenue and Volume Forecast, by Application

13.5.6.4. Market Revenue and Volume Forecast, by End-User

13.5.7. Market Revenue and Volume Forecast, by Technology

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Volume Forecast, by Technique

13.5.8.2. Market Revenue and Volume Forecast, by Product

13.5.8.3. Market Revenue and Volume Forecast, by Application

13.5.8.4. Market Revenue and Volume Forecast, by End-User

13.5.8.5. Market Revenue and Volume Forecast, by Technology

Chapter 14. Company Profiles

14.1. Thermo Fisher Scientific

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. PerkinElmer

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Hoffmann-La Roche

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Abbott Laboratories

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. MetaSystems

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Myriad Genetics

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. BioDot

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. MetaSystems

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. SciGene

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Biocare Medical

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The molecular cytogenetics market size is expected to increase from USD 2.86 billion in 2025 to USD 7.82 billion by 2034.

The molecular cytogenetics market is expected to grow at a compound annual growth rate (CAGR) of around 11.81% from 2025 to 2034.

The major players in the molecular cytogenetics market include Thermo Fisher Scientific, PerkinElmer, Hoffmann-La Roche, Abbott Laboratories, MetaSystems, Biocept, Personal Genome Diagnostics, Myriad Genetics, BioDot, and Biocare Medical

The driving factors of the molecular cytogenetics market are the driven by the growing adoption of advanced genomic technologies for the precise detection of genetic abnormalities in cancer and congenital disorders.

North America region will lead the global molecular cytogenetics market during the forecast period 2025 to 2034.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client

//